Pifenidone Prophylactic Therapy for Radiation Lung Injury in Patients Who Have Previously Received Immune Checkpoint Inhibitors
Hubei Cancer Hospital
Hubei Cancer Hospital
The First Affiliated Hospital of Guangzhou Medical University
University of Turin, Italy
Sichuan University
Vestre Viken Hospital Trust
The First People's Hospital of Lianyungang
University of Turin, Italy
Shanghai Chest Hospital
Oslo University Hospital
National Hospital Organization Nagoya Medical Center
Shanghai Cancer Hospital, China
Jiangsu HengRui Medicine Co., Ltd.
Samsung Medical Center
Henan Cancer Hospital
Tianjin Medical University Cancer Institute and Hospital
Seoul St. Mary's Hospital
Sun Yat-sen University
Aalborg University Hospital
Zhejiang Cancer Hospital
Soroka University Medical Center
Guangdong Association of Clinical Trials
Kyunghee University Medical Center
Jiangsu HengRui Medicine Co., Ltd.
Shanghai Chest Hospital
Hebei Medical University
Massachusetts General Hospital
Accuray Incorporated
First People's Hospital of Hangzhou
Hanlim Pharm. Co., Ltd.
Fudan University
MetiMedi Pharmaceuticals
Sun Yat-sen University
Shanghai Cancer Hospital, China
Tianjin Medical University Second Hospital
Sun Yat-sen University
The First Affiliated Hospital of Xiamen University
Shandong Cancer Hospital and Institute
Guangzhou Institute of Respiratory Disease
Betta Pharmaceuticals Co., Ltd.
Zhejiang Cancer Hospital
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Xuanwu Hospital, Beijing
British Columbia Cancer Agency
First Hospital of Shijiazhuang City
First Hospital of Shijiazhuang City
Velindre NHS Trust
Guangzhou Institute of Respiratory Disease
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Sichuan Cancer Hospital and Research Institute
Ain Shams University